Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Bronchopulmonary aspergillosis

Not recruiting

Investigational

Study on the Safety and Effectiveness of Opelconazole with Other Antifungal Treatments for Patients with Hard-to-Treat Lung Aspergillosis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Opelconazole

Contact Research Centre

Multiple sclerosis

Not recruiting

Investigational

Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Investigational

Spain

Participants:18–64 years
Substances:Frexalimab

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Type 2 diabetes mellitus+2

Not recruiting

Registered drug

Study of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Semaglutide

Contact Research Centre

Juvenile psoriatic arthritis

Not recruiting

Registered drugNo placebo

Study on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis

Registered drugNo placebo

Spain

Participants:0–17 years
Substances:Guselkumab

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

Registered drugNo placebo

Study Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Primary progressive multiple sclerosis

Not recruiting

Investigational

Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis

Investigational

Spain

Participants:18–64 years
Substances:Tolebrutinib

Contact Research Centre

Hormone receptor positive breast cancer

Not recruiting

InvestigationalNo placebo

Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Palbociclib

Contact Research Centre

Find therapies in clinical trials near you – page 28

564 trials match your criteria

Neurotrophic keratopathy

Study on the Safety and Effectiveness of Timbetasin Acetate Eye Drops for Patients with Neurotrophic Keratopathy

Hormone-refractory prostate cancer+2

Study of Fuzuloparib, Abiraterone Acetate, and Prednisone for First-Line Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer

Bladder cancer recurrent+1

Study on Mycobacterium Bovis Bacillus Calmette-Guérin for High-risk Non-muscle Invasive Bladder Cancer Patients

Neurodermatitis

Study on the Effects of Povorcitinib for Patients with Prurigo Nodularis

Bronchopulmonary aspergillosis

Study on the Safety and Effectiveness of Opelconazole with Other Antifungal Treatments for Patients with Hard-to-Treat Lung Aspergillosis

Multiple sclerosis

Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Hormone receptor positive HER2 negative breast cancer

Study on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer

Type 2 diabetes mellitus+2

Study of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes

Juvenile psoriatic arthritis

Study on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis

Non-small cell lung cancer+1

Study Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer

Primary progressive multiple sclerosis

Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis

Hormone receptor positive breast cancer

Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.